|
FY2025
12 months to Dec 27, 2025
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 25, 2021
|
|
|---|---|---|---|---|---|
| Cash flows relating to operating activities | |||||
| Net income (loss) | |||||
| Adjustments to reconcile net income (loss) to net cash provided by operating activities: | |||||
| Depreciation and amortization | |||||
| Goodwill impairment | |||||
| Long-lived asset impairments | |||||
| Stock-based compensation | |||||
| Loss on debt extinguishment and amortization of other financing costs | |||||
| Deferred income taxes | |||||
| Write down of inventories | |||||
| (Gains) losses and impairments on venture capital and strategic equity investments, net | |||||
| Provision for credit losses | |||||
| (Gain) loss on divestitures, net | |||||
| Changes in fair value of contingent consideration arrangements | |||||
| Other, net | |||||
| Changes in assets and liabilities: | |||||
| Trade receivables and contract assets, net | |||||
| Inventories | |||||
| Accounts payable | |||||
| Accrued compensation | |||||
| Deferred revenue | |||||
| Customer contract deposits | |||||
| Other assets and liabilities, net | |||||
| Net cash provided by operating activities | |||||
| Cash flows relating to investing activities | |||||
| Capital expenditures | |||||
| Purchases of investments and contributions to venture capital investments | |||||
| Acquisition of businesses and assets, net of cash acquired | |||||
| Proceeds from sale of investments | |||||
| Proceeds from sale of businesses, net | |||||
| Other, net | |||||
| Net cash used in investing activities | |||||
| Cash flows relating to financing activities | |||||
| Proceeds from long-term debt and revolving credit facility | |||||
| Payments on long-term debt, revolving credit facility, and finance lease obligations | |||||
| Proceeds from exercises of stock options | |||||
| Purchase of treasury stock | |||||
| Payment of debt extinguishment and financing costs | |||||
| Payments of contingent consideration | |||||
| Purchase of remaining equity interests of other redeemable noncontrolling interest | |||||
| Other, net | |||||
| Net cash used in financing activities | |||||
| Effect of exchange rate changes on cash, cash equivalents, and restricted cash | |||||
| Net change in cash, cash equivalents, and restricted cash | |||||
| Cash, cash equivalents, and restricted cash, beginning of period | |||||
| Cash, cash equivalents, and restricted cash, end of period | |||||
| Cash paid for income taxes | |||||
| Cash paid for interest | |||||
| Purchases of Property, plant and equipment included in Accounts payable and Accrued liabilities | |||||
| Assets acquired under finance leases | |||||
| Cash and cash equivalents | |||||
Loading...
